elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28659468-2F4C5F6A-5B2F-4E5E-A63A-30D51E0CAC45
Q28659468-2F4C5F6A-5B2F-4E5E-A63A-30D51E0CAC45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28659468-2F4C5F6A-5B2F-4E5E-A63A-30D51E0CAC45
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
P2860
Q28659468-2F4C5F6A-5B2F-4E5E-A63A-30D51E0CAC45
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28659468-2F4C5F6A-5B2F-4E5E-A63A-30D51E0CAC45
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e30a6a647d5f76957e298e5d075815fd841a6a25
P2860
Clinical trials in metastatic prostate cancer--has there been real progress in the past decade?